North America Chinese Hamster Ovary (CHO) Cells Market – Industry Trends and Forecast to 2030

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

North America Chinese Hamster Ovary (CHO) Cells Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Nov 2023
  • North America
  • 350 Pages
  • No of Tables: 63
  • No of Figures: 35

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TREATMENT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 NORTH AMERICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET, REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY

6.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS

6.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D

6.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES

6.2 RESTRAINTS

6.2.1 HIGH-COST OF CHO CELL-BASED PRODUCTION

6.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION

6.3 OPPORTUNITIES

6.3.1 CONTINUOUS DEVELOPMENT OF CELL CULTURE TECHNOLOGIES

6.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS

6.4 CHALLENGES

6.4.1 TIME-CONSUMING AND INCONSISTENCY IN THE CHO CELL LINE DEVELOPMENT PROCESS

6.4.2 CONTAMINATION RISK OF CHO CELL CULTURES

7 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE

7.1 OVERVIEW

7.2 SERVICES

7.3 PRODUCT

7.3.1 CHO-DXB11

7.3.2 CHO-K1

7.3.2.1 CHO-K1 ATCC

7.3.2.2 CHO-K1 ECACC

7.3.2.3 OTHERS

7.3.3 CHO-DG44

7.3.4 CHO-S

7.3.5 OTHERS

8 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM

8.1 OVERVIEW

8.2 METABOLIC SELECTION SYSTEM

8.3 ANTIBIOTIC SELECTION SYSTEM

8.4 OTHERS

9 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 BIOLOGICS

9.2.1 MONOCLONAL ANTIBODIES

9.2.2 ENZYMES

9.2.3 CYTOKINES

9.2.4 CLOTTING FACTORS

9.2.5 HORMONES

9.2.6 FC-FUSION PROTIEN

9.2.7 OTHERS

9.3 MEDICAL RESEARCH

10 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOPHARMACEUTICAL COMPANIES

10.2.1 MEDIUM

10.2.2 SMALL

10.3 BIOTECHNOLOGY COMPANIES

10.3.1 MEDIUM

10.3.2 SMALL

10.4 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS

10.4.1 MEDIUM

10.4.2 SMALL

10.5 CLINICAL RESEARCH ORGANIZATIONS

10.5.1 MEDIUM

10.5.2 SMALL

10.6 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS

10.7 OTHERS

11 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDERS

11.3 RETAIL SALES

11.4 OTHERS

12 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET BY COUNTRY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 LONZA

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENT

15.2 SARTORIUS AG

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 PRODUCT PORTFOLIO

15.2.4 RECENT DEVELOPMENT

15.3 MERCK KGAA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENT

15.4 CYTIVA

15.4.1 COMPANY SNAPSHOT

15.4.2 PRODUCT PORTFOLIO

15.4.3 RECENT DEVELOPMENT

15.5 THERMO FISHER SCIENTIFIC INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 ABEOMICS

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENT

15.7 ACCEGEN

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM)

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 ATCC

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BPS BIOSCIENCE, INC.

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 CLS CELL LINES SERVICE GMBH

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 CURIA GLOBAL, INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 GENTARGET INC.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 HORIZON DISCOVERY LTD.

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 PROMEGA CORPORATION

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 RAYBIOTECH LIFE, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2022-2030 (USD THOUSAND)

TABLE 2 NORTH AMERICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 3 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 4 NORTH AMERICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 5 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 6 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)

TABLE 7 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 8 NORTH AMERICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 9 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 10 NORTH AMERICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 11 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 12 NORTH AMERICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 13 NORTH AMERICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 14 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD THOUSAND)

TABLE 15 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 16 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 17 U.S. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 18 U.S. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 19 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 20 U.S. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 21 U.S. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 22 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 23 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)

TABLE 24 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 25 U.S. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 26 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 27 U.S. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 28 U.S. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 29 U.S. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 30 U.S. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 31 U.S. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 32 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 33 CANADA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 34 CANADA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 35 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 36 CANADA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 37 CANADA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 38 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 39 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)

TABLE 40 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 41 CANADA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 42 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 43 CANADA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 44 CANADA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 45 CANADA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 46 CANADA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 47 CANADA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 48 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 49 MEXICO PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 50 MEXICO PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 51 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 52 MEXICO CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 53 MEXICO CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP

TABLE 54 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)

TABLE 55 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)

TABLE 56 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 57 MEXICO BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 58 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 59 MEXICO BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 60 MEXICO BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 61 MEXICO CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 62 MEXICO CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 63 MEXICO CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

List of Figure

FIGURE 1 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION

FIGURE 11 RISING DEMAND FOR BIOLOGICS AND THERAPEUTIC PROTEINS EXPECTED TO DRIVE THE NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET IN THE FORECAST PERIOD OF 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET

FIGURE 14 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2022

FIGURE 15 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2023-2030 (USD THOUSAND)

FIGURE 16 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2022

FIGURE 19 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2023-2030 (USD THOUSAND)

FIGURE 20 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, LIFELINE CURVE

FIGURE 22 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2022

FIGURE 23 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 24 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022

FIGURE 27 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 28 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)

FIGURE 32 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SNAPSHOT (2022)

FIGURE 35 NORTH AMERICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2022 (%)

Frequently Asked Questions

The market is segmented based on North America Chinese Hamster Ovary (CHO) Cells Market, By Type (Services and Product), System (Metabolic Selection System, Antibiotic Selection System and Others), Application (Biologics and Medical Research), End User (Biopharmaceutical Companies, Biotechnology Companies, Clinical Development and Manufacturing Organizations, Clinical Research Organizations, Academic Institutes and Research Organizations, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) - Industry Trends and Forecast to 2030. .
The North America Chinese Hamster Ovary Cells Cho Market size was valued at USD 143106.10 USD Thousand in 2022.
The North America Chinese Hamster Ovary Cells Cho Market is projected to grow at a CAGR of 8.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, and Mexico.